Pharmaceutical Analysis & Statistics in Canada, August 2014

You might be interested in: therapeutics, drug, cancer, more »

1-50 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business ...

  • Industries : Therapy
  • Countries : World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom
Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : United States, World, Australia, Canada
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024

Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024

  • $ 3 013
  • Industry report
  • June 2014
  • by Visiongain

Report Details Epigenetics market - new analysis showing you technological trends and sales forecasts Do you want to find sales potentials of epigenetic technologies, diagnostics and medicines? Now get ...

  • Industries : Pathology
  • Countries : World, Canada, United States
Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

  • $ 2 488
  • Industry report
  • July 2014
  • by MarketSizeInfo

This is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vitamins and provitamins. The publication provides the market size, growth ...

  • Industries : Vitamin and Supplement
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, North America, Peru, Oman
Osteoarthritis Pain - Pipeline Review, H2 2014

Osteoarthritis Pain - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

Osteoarthritis Pain - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Osteoarthritis Pain - Pipeline Review, H2 2014', provides an overview of the Osteoarthritis Pain's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : United States, Canada, World
Canada Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Canada Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: According to the Canadian Institute for Health Information, the growth of spending on prescription drugs in Canada slowed to its lowest level since 1996 in ...

  • Industries : Drug and Medication
  • Countries : Canada
JenaValve Technology GmbH - Product Pipeline Analysis, 2014 Update

JenaValve Technology GmbH - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • July 2014
  • by Global Data

Summary JenaValve Technology GmbH (JenaValve) is a medical device company. The company designs and develops minimally invasive heart valve replacement systems for the cardiovascular markets. It concentrates ...

  • Industries : Drug Discovery and Development
  • Countries : Argentina, Canada, Germany
Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2014 Update

Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

Summary Becton, Dickinson and Company (BD) is a medical technology company. It manufactures and sells medical devices, reagents and instrument systems used by life science researchers, healthcare institutions, ...

  • Industries : Pathology
  • Countries : Canada, United States
Soricimed Biopharma Inc. - Product Pipeline Analysis, 2014 Update

Soricimed Biopharma Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

Summary Soricimed Biopharma Inc. (Soricimed), formerly BioProspecting NB Inc. is a drug development company. The company carries out the development and commercialization of therapeutic and diagnostic ...

  • Industries : Pathology
  • Countries : Canada
Abacavir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Abacavir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Acitretin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Acitretin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Adefovir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Adefovir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Armodafinil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Armodafinil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Atovaquone  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Atovaquone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Brinzolamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Brinzolamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Caspofungin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Caspofungin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Celecoxib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Celecoxib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Duloxetine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Duloxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Dutasteride  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Dutasteride - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Frovatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Frovatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Galantamine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Galantamine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Ibandronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ibandronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Imatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Imatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Lasofoxifene  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Lasofoxifene - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Linezolid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Linezolid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Modafinil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Modafinil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Pitavastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Pitavastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Posaconazole  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Posaconazole - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
About 2 200 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry - Company Report, August 2014

  • Do Faster Drug Approvals Increase Safety Risks? Evidence from Ca...
  • August 2014
    9 pages
  • Drug  

  • Canada  

    Europe  

    North America  

View report >

15 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.